NCT05147402View on ClinicalTrials.gov

Food Effects on Bioavailability of MDMA in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL

Enrollment

14

Participants

Timeline

Start Date

July 28, 2022

Primary Completion Date

December 2, 2022

Study Completion Date

December 5, 2022

Conditions

Pharmacokinetics

Interventions

DRUG

midomafetamine

100 mg midomafetamine (equivalent to 120 mg midomafetamine HCl).

Trial Locations (1)

37920

Alliance for Multispecialty Research LLC, Knoxville

Sponsors

Lead Sponsor

Lykos Therapeutics

All Listed Sponsors

lead

Lykos Therapeutics

INDUSTRY

NCT05147402 - Food Effects on Bioavailability of MDMA in Healthy Volunteers | Biotech Hunter | Biotech Hunter